Adma Biologics reported $138.23M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Adma Biologics USD 138.23M 2.37M Jun/2026
Alnylam Pharmaceuticals USD 1.08B 172.17M Sep/2026
BioCryst Pharmaceuticals USD 110.76M 3.94M Jun/2026
Novavax USD 106.45M 72.27M Dec/2025
Omeros USD 8.08M 440K Jun/2024
Takeda JPY 910.24B 45.9B Sep/2026